Business
Launch of web-based testing for virtual research
Launch of web-based testing for virtual research.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 6706Y Cambridge Cognition Holdings PLC 07 March 2017 \n\n07 March 2017\n \nCambridge Cognition Holdings Plc\n('Cambridge Cognition' or the 'Company')\n \nCambridge Cognition launches web-based testing for virtual research\n \nThe global neuroscience digital health company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets software products to improve brain health, today announces the launch of a new web-based testing product for conducting academic and clinical research studies online.\nDisorders affecting the brain are now the leading cause of disability and ill health worldwide. More than 1,000 disorders of the brain and central nervous system (CNS) result in huge costs, more hospitalisations and loss of productivity than any other disease group, including heart disease and cancer1.\nAdvances in research will improve this outlook but administrative costs, inadequate research tools and limited access to patient populations can slow progress.\nTo support neuroscience research, CANTAB Connect, the worlds most validated cognitive assessment software now enables researchers to assess participants on a global scale, in a quick and cost-effective manner.\nCambridge Cognition's CANTAB® technology has been used to measure cognitive function in leading academic and industry research for over 30 years. The Company now markets a range of digital health products on mobile and wearable devices to help recruit participants into clinical trials, validate treatment efficacy and monitor brain health in daily life.\nWeb-based testing is the latest innovation, empowering researchers to run near-patient testing of participants remotely. The innovation will allow studies to gather digital cognitive biomarkers at frequent time-points for more accurate and rapid data to aid earlier decision-making and conduct large-scale research projects virtually, reducing the overall running costs of studies using proven neuropsychological assessments.\nDr Steven Powell, Chief Executive Officer, Cambridge Cognition, commented: \"The increasing prevalence of neurological and psychiatric disorders including depression, Parkinson's and Alzheimer's disease has resulted in a growing need for innovative neuroscience digital health tools. Web-based testing using CANTAB Connect is a key part of ou...